Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong W Kim

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Ecology & Evolution|November 7, 2022
Reply to: Existing methods are effective at measuring natural selection on gene expressionPeter D Price, Daniela H Palmer Droguett, Jessica A Taylor, et al.
British Journal of Anaesthesia|October 9, 2019
Tramadol use is associated with enhanced postoperative outcomes in breast cancer patients: a retrospective clinical study with in vitro confirmationMyoung H Kim, Ju E Oh, Seho Park, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical TrialAsal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
BMC Cell Biology|July 2, 2010
Transdifferentiation-inducing HCCR-1 oncogeneSeon-Ah Ha, Hyun K Kim, JinAh Yoo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 27, 2004
Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based studyHee J An, Kyu R Kim, In S Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T TherapyForat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Ecology & Evolution|November 7, 2022
Reply to: Existing methods are effective at measuring natural selection on gene expressionPeter D Price, Daniela H Palmer Droguett, Jessica A Taylor, et al.
British Journal of Anaesthesia|October 9, 2019
Tramadol use is associated with enhanced postoperative outcomes in breast cancer patients: a retrospective clinical study with in vitro confirmationMyoung H Kim, Ju E Oh, Seho Park, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical TrialAsal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
BMC Cell Biology|July 2, 2010
Transdifferentiation-inducing HCCR-1 oncogeneSeon-Ah Ha, Hyun K Kim, JinAh Yoo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 27, 2004
Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based studyHee J An, Kyu R Kim, In S Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2023
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T TherapyForat Lutfi, Olga Goloubeva, Amer Kowatli, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Pageof 4